X4 Pharmaceuticals, Inc.XFORNASDAQ

Revenue (LTM)

$35M

+1273.2% YoY

Net Income (LTM)

$-79M

-111.5% YoY

Free Cash Flow

$-86M

Revenue CAGR (5Y)

—

Marginsimproving

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	3	35↑1273.2%
Gross Profit	0	0	0	2	29↑1568.0%
Operating Income	-85	-88↓2.9%	-108↓22.8%	-36↑66.1%	-87↓138.7%
Net Income	-89	-94↓5.8%	-101↓7.8%	-37↑63.0%	-79↓111.5%
EBITDA	-85	-89↓5.7%	-95↓6.2%	-28↑70.9%	-86↓210.4%
EPS Diluted	-119.70	-45.60↑61.9%	-17.10↑62.5%	-5.59↑67.3%	-1.87↑66.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	82	122↑48.8%	99↓18.5%	56↓43.9%	217↑289.7%
Total Current Assets	88	129↑46.4%	122↓5.1%	112↓8.1%	262↑133.2%
Total Assets	117	156↑32.8%	147↓5.4%	146↓0.6%	290↑98.3%
Total Current Liabilities	14	22↑59.2%	23↑2.4%	33↑43.8%	26↓21.7%
Total Liabilities	53	82↑54.5%	96↑17.9%	124↑29.3%	104↓16.2%
Total Equity	64	74↑15.0%	51↓31.0%	22↓56.7%	186↑741.1%
Total Debt	40	38↓3.4%	58↑51.7%	78↑34.0%	77↓1.0%
Net Debt	-42	-83↓98.3%	-41↑50.9%	22↑154.7%	-140↓724.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-71	-77↓8.7%	-97↓25.2%	-131↓35.6%	-86↑34.6%
Capital Expenditure	-1	-0↑83.3%	-0↑41.7%	-0↓443.3%	0
Free Cash Flow	-72	-77↓7.9%	-97↓25.1%	-131↓35.9%	-86↑34.8%
Stock-Based Comp	6	5↓15.9%	9↑67.1%	8↓5.6%	4↓47.6%
Net Change in Cash	2	40↑1559.2%	-23↓157.1%	-44↓92.2%	161↑468.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance